化瘀抗幽方联合西药治疗幽门螺杆菌相关性溃疡临床研究

2015-10-21 18:44:32蒲勤等
中国中医药信息杂志 2015年9期
关键词:幽门螺杆菌

蒲勤等

摘要:目的 观察化瘀抗幽方联合西药治疗幽门螺杆菌(Hp)相关性溃疡临床疗效,并探讨其作用机理。方法 将152例患者随机分为治疗组和对照组各76例,对照组予标准三联疗法,治疗组在标准三联疗法基础上予自拟方化瘀抗幽汤治疗,疗程6周,观察2组患者治疗前后临床症状积分、胃镜,记录不良反应,评价临床疗效,随访溃疡复发情况。结果 治疗组、对照组临床总有效率分别为94.74%(72/76)、84.21%(64/76),治疗优良率分别为78.95%(60/76)、55.26%(42/76),不良反应发生率分别为5.26%(4/76)、13.16%(10/76),随访1年复发率分别为13.63%(6/44)、41.67%(10/24),差异均有统计学意义(P<0.05)。结论 化瘀抗幽方联合西药治疗Hp相关性溃疡能够提高临床疗效,减少不良反应,降低溃疡复发率。

关键词:化瘀抗幽方;标准三联疗法;消化性溃疡;幽门螺杆菌

DOI:10.3969/j.issn.1005-5304.2015.09.009

中图分类号:R259.731.1 文献标识码:A 文章编号:1005-5304(2015)09-0030-04

Clinical Study on Huayu Kangyou Formula Combined with Western Medicine for Hp-related Peptic Ulcer Disease PU Qin1, WEI Shu-hai2, WANG Jin-yang3, XU Jian1, SUN Cheng-gang1, WEI Li-bao1, GUO Feng-zhong1 (1.Fourth People's Hospital of Tianshui City, Tianshui 741020, China;2.Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou 730020, China;3.Gansu University of Chinese Medicine, Lanzhou 730020, China)

Abstract:Objective To observe the efficacy of Huayu Kangyou Formula combined with Western medicine for Hp-related peptic ulcer disease;To discuss the mechanism of action. Methods Totally 152 patients were randomly divided into treatment group and control group, 76 cases in each group. Control group was given standard triple therapy, while treatment group was given Huayu Kangyou Formula based on the standard triple therapy. The treatment lasted for 6 weeks. The clincal symptom scores and gastroscopy were observed to evaluate the therapeutic effect, adverse reactions were recorded, and relapse of ulcer was followed-up. Results The total effective rates of clinical symptoms in the treatment group and the control group were 94.74% (72/76) and 84.21% (64/76), respectively;the excellent rates were 78.95% (60/76) and 55.26% (42/76), respectively;the incidences of adverse reactions were 5.26% (4/76) and 13.16% (10/76), respectively;the relapse rates after 1 year of follow-up visit were 13.63% (6/44) and 41.67% (10/24), respectively, with statistical significant difference between the two groups (P<0.05). Conclusion Huayu Kangyou Formula combined with Western medicine can effectively improve the efficacy of Hp-relative peptic ulcer disease, reduce adverse reaction rate and relapse rate.

Key words:Huayu Kangyou Formula;standard triple therapy;peptic ulcer;Hp

消化性潰疡主要指胃和十二指肠黏膜被胃酸、胃蛋白酶自身消化所致的局限性组织缺损、炎症与坏死性病变[1],其发病与幽门螺杆菌(Hp)感染关系密切[2],故对Hp阳性者又称Hp相关性溃疡。流行病学调查显示,95%以上的十二指肠溃疡及70%~85%的胃溃疡与Hp感染有关[3]。目前,Hp相关性溃疡的西医治疗临床指南明确,以标准三联或四联疗法为代表,其治疗虽有效,但患者在根除Hp、抑制胃酸后消化性溃疡并非都能愈合,或愈合后在一定时间复发[4]。笔者在标准三联疗法的基础上,联合运用自拟化瘀抗幽方治疗Hp相关性溃疡,观察其临床疗效和复发情况,现报道如下。

1 临床资料

1.1 一般资料

经天水市第四人民医院及甘肃中医药大学附属医院伦理委员会批准,收集2012年6月-2013年11月就诊于两院的消化性溃疡患者共152例,采用随机数字法随机均分为治疗组和对照组各76例。……

登录APP查看全文

猜你喜欢
幽门螺杆菌
胃溃疡采用埃索美拉唑和奥美拉唑治疗的对比
含呋喃唑酮四联疗法与标准三联疗法根除幽门螺杆菌的效果比较
湖州地区651例糖尿病患者幽门螺杆菌耐药情况调查分析
“幽门螺杆菌”那些事儿
家庭用药(2016年9期)2016-12-03 08:34:20
抗幽门螺杆菌治疗对急性冠脉综合征合并幽门螺杆菌感染患者的近期疗效
维、哈、汉族体检者Hp感染危险因素的回归分析
疏肝和胃颗粒联合四联疗法治疗Hp相关性慢性非萎缩性胃炎
含铋剂的四联疗法与标准三联疗法对幽门螺杆菌相关性消化性溃疡的疗效对比
幽门螺杆菌感染与特发性血小板减少性紫癜发病与转归的关系
根除幽门螺杆菌治疗对功能性消化不良患者临床症状的疗效观察